Aprea Therapeutics Common stock (APRE) Q3 2024 Earnings

12AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1.16
-0.97
-0.77
-0.58

Details

Expected EPS
-0.616333
Actual EPS
-0.58
Surprise EPS
0.04
Surprise Percent
+5.9%

Description

Aprea Therapeutics Common stock (APRE) has reported earnings of -0.58 per share for Q3 2024.

0 Comments

Share your thoughts